Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

S100A6 protein is linked to disease progression, especially in cancers.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

IL-17-producing γδ T cells help improve bone healing.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Certain proteins and cytokines are key in causing psoriatic skin issues.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Sdr16c5 and Sdr16c6 genes regulate a key point in lipid production that affects eye and skin gland function.

Integrin alpha-6 and p63 proteins may play a role in hair loss and are important for hair growth and maintenance.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.